The Gfi-1B Proto-Oncoprotein Represses p21^WAF1 and Inhibits Myeloid Cell Differentiation

REFERENCES

• Anderson, S., D. H. Davis, H. Dahlbäck, H. Jörnvall, and D. W. Russell 1989. Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile biosynthetic enzyme. J. Biol. Chem. 264: 8222–8229.
   PubMed Web of Science ®Google Scholar
• Arnaout, M. A. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75: 1037–1050.
   PubMed Web of Science ®Google Scholar
• Bell, D. W., T. Taguchi, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, C. B. Gilks, P. Zweidler-McKay, H. L. Grimes, P. N. Tsichlis, and J. R. Testa 1995. Chromosomal localization of a gene, GFI1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents. Cytogenet. Cell Genet. 70: 263–267.
   PubMedGoogle Scholar
• Bies, J., B. Hoffman, A. Amanullah, T. Giese, and L. Wolff 1996. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12: 355–363.
   PubMedGoogle Scholar
• Biggs, J. R., J. E. Kudlow, and A. S. Kraft 1996. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271: 901–906.
   PubMed Web of Science ®Google Scholar
• Bignon, C., D. Daniel, and J. Dijiane 1993. β-Galactosidase and chloramphenicol acetyltransferase assays in 96-well plates. BioTechniques 15: 243–245.
   PubMedGoogle Scholar
• Bosari, S., and G. Viale 1995. The clinical significance of p53 aberrations in human tumors. Virchows Arch. 427: 229–241.
   PubMed Web of Science ®Google Scholar
• Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272: 719–722.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and N. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Collins, S. J., S. Tsai, and I. Bernstein 1996. Retinoic acid receptors in hematopoiesis. Curr. Top. Microbiol. Immunol. 211: 7–15.
   PubMedGoogle Scholar
• Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, Bast R. C., Jr., J. D. Iglehart, and J. R. Marks 1994. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5: 1301–1307.
   PubMedGoogle Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, T. Waldman, J. D. Oliner, V. E. Velculescu, M. Burrell, D. E. Hill, E. Healy, J. L. Rees, S. R. Hamilton, K. W. Kinzler, and B. Vogelstein 1995. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55: 2910–2919.
   PubMed Web of Science ®Google Scholar
• Elledge, S. J., J. Winston, and J. W. Harper 1996. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol. 6: 388–392.
   PubMed Web of Science ®Google Scholar
• Gearing, D. P., N. M. Gough, J. A. King, D. J. Hilton, N. A. Nicola, R. J. Simpson, E. C. Nice, A. Kelso, and D. Metcalf 1987. Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J. 6: 3995–4002.
   PubMed Web of Science ®Google Scholar
• Gilks, C. B., S. E. Bear, H. L. Grimes, and P. N. Tsichlis 1993. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol. Cell. Biol. 13: 1759–1768.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044–1051.
   PubMed Web of Science ®Google Scholar
• Graña, X., and E. P. Reddy 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211–219.
   PubMed Web of Science ®Google Scholar
• Grimes, H. L., T. O. Chan, P. A. Zweidler-McKay, B. Tong, and P. N. Tsichlis 1996. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol. Cell. Biol. 16: 6263–6272.
   PubMed Web of Science ®Google Scholar
• Grimes, H. L., C. B. Gilks, T. O. Chan, S. Porter, and P. N. Tsichlis 1996. The Gfi-1 proto-oncoprotein represses Bax expression and inhibits T-cell death. Proc. Natl. Acad. Sci. USA 93: 14569–14573.
   PubMed Web of Science ®Google Scholar
• Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018–1021.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., and S. J. Elledge 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6: 56–64.
   PubMed Web of Science ®Google Scholar
• Harvey, D. M., and A. J. Levine 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5: 2375–2385.
   PubMed Web of Science ®Google Scholar
• Hawley, R. G., F. H. L. Lieu, A. Z. C. Fong, and T. S. Hawley 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1: 1–11.
   PubMedGoogle Scholar
• Hoffman-Liebermann, B., and D. A. Liebermann 1991. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol. Cell. Biol. 11: 2375–2381.
   PubMed Web of Science ®Google Scholar
• Hoffman-Liebermann, B., and D. A. Liebermann 1991. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene 6: 903–909.
   PubMedGoogle Scholar
• Jiang, H., J. Lin, Z. Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397–3406.
   PubMed Web of Science ®Google Scholar
• Johnson, M., D. Dimitrov, P. J. Vojta, J. C. Barrett, A. Noda, O. M. Pereira-Smith, and J. R. Smith 1994. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog. 11: 59–64.
   PubMed Web of Science ®Google Scholar
• Kelley, K. W., S. Arkins, C. Minshall, Q. Liu, and R. Dantzer 1996. Growth hormone, growth factors and hematopoiesis. Horm. Res. 45: 38–45.
   PubMed Web of Science ®Google Scholar
• Kramer, A., and W. Keller 1990. Preparation and fractionation of mammalian extracts active in pre-mRNA splicing. Methods Enzymol. 181: 3–19.
   PubMedGoogle Scholar
• Krystosek, A., and L. Sachs 1976. Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell 9: 675–684.
   PubMedGoogle Scholar
• Lan, M. S., E. K. Russell, J. Lu, B. E. Johnson, and A. L. Notkins 1993. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res. 53: 4169–4171.
   PubMedGoogle Scholar
• Lew, D. J., and S. Kornbluth 1996. Regulatory roles of cyclin-dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol. 8: 795–804.
   PubMed Web of Science ®Google Scholar
• Li, H., P. S. Zeitler, M. T. Valerius, K. Small, and S. S. Potter 1996. Gsh-1, an orphan Hox gene, is required for normal pituitary development. EMBO J. 15: 714–724.
   PubMedGoogle Scholar
• Liebermann, D. A., and B. Hoffman 1994. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Stem Cells 12: 352–369.
   PubMedGoogle Scholar
• Liu, M., M. H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10: 142–153.
   PubMed Web of Science ®Google Scholar
• Liu, M., A. Iavarone, and L. P. Freedman 1996. Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271: 31723–31728.
   PubMed Web of Science ®Google Scholar
• Meier, R. W., T. Chen, S. Mathews, G. Niklaus, and A. Tobler 1992. The differentiation pathway of HL60 cells is a model system for studying the specific regulation of some myeloid genes. Cell Growth Differ. 3: 663–669.
   PubMedGoogle Scholar
• Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54: 3391–3395.
   PubMed Web of Science ®Google Scholar
• Mikkers, H., and A. Berns. Personal communication.
   Google Scholar
• Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G. P. Dotto 1996. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10: 3065–3075.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374: 131–134.
   PubMed Web of Science ®Google Scholar
• Orkin, S. H. 1996. Development of hematopoietic system. Curr. Opin. Genet. Dev. 6: 597–602.
   PubMedGoogle Scholar
• Prowse, D. M., L. Bolgan, A. Molnar, and G. P. Dotto 1997. Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J. Biol. Chem. 272: 1308–1314.
   PubMed Web of Science ®Google Scholar
• Puri, P. L., M. L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and M. Levrero 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16: 369–383.
   PubMed Web of Science ®Google Scholar
• Ryan, K., I. Hayes, R. J. B. Nibbs, J. W. Baird, B. Tong, P. N. Tsichlis, J. D. Ansell, N. Hole, and G. J. Graham. Submitted for publication.
   Google Scholar
• Sachs, L. 1990. The control of growth and differentiation in normal and leukemic blood cells. Cancer 65: 2196–2206.
   PubMed Web of Science ®Google Scholar
• Sachs, L. 1996. The control of hematopoiesis and leukemia: from basic biology to the clinic. Proc. Natl. Acad. Sci. USA 93: 4742–4749.
   PubMed Web of Science ®Google Scholar
• Scheijen, B., J. Jonkers, D. Acton, and A. Berns 1997. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J. Virol. 71: 9–16.
   PubMed Web of Science ®Google Scholar
• Schmidt, T., M. Zornig, R. Beneke, and T. Moroy 1996. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res. 24: 2528–2534.
   PubMed Web of Science ®Google Scholar
• Selvakumaran, M., D. A. Liebermann, and B. Hoffman-Liebermann 1992. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol. Cell. Biol. 12: 2493–2500.
   PubMed Web of Science ®Google Scholar
• Shabo, Y., J. Lotem, M. Rubinstein, M. Revel, S. C. Clark, S. F. Wolf, R. Kamen, and L. Sachs 1988. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 72: 2070–2073.
   PubMed Web of Science ®Google Scholar
• Sherley, J. L., and T. J. Kelly 1988. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263: 8350–8358.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149–1163.
   PubMed Web of Science ®Google Scholar
• Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022–1024.
   PubMed Web of Science ®Google Scholar
• Smith, R. C., D. Branellec, D. H. Gorski, K. Guo, H. Perlman, J.-F. Dedieu, C. Pastore, A. Mahfoudi, P. Denèfle, J. M. Isner, and K. Walsh 1997. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11: 1674–1689.
   PubMed Web of Science ®Google Scholar
• Somasundaram, K., H. Zhang, Y.-X. Zeng, Y. Houvras, Y. Peng, H. Zhang, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El-Deiry 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CIP1. Nature 389: 187–190.
   PubMed Web of Science ®Google Scholar
• Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. el-Houseini 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389–3396.
   PubMed Web of Science ®Google Scholar
• Timchenko, N. A., M. Wilde, M. Nakanishi, J. R. Smith, and G. J. Darlington 1996. CCAAT/enhancer-binding protein α (C/EBP α) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10: 804–815.
   PubMed Web of Science ®Google Scholar
• Tong, B. 1997. Gfi-1B represses p21^WAF1 expression and inhibits myeloid cell differentiation. Ph.D. thesis. University of Pennsylvania, Philadelphia.
   Google Scholar
• Tong, B., N. Copeland, and N. Jenkins. Unpublished data.
   Google Scholar
• Vasavada, H. A., S. Ganguly, F. J. Germino, Z. X. Wang, and S. M. Weissman 1991. A contingent replication assay for the detection of protein-protein interactions in animal cells. Proc. Natl. Acad. Sci. USA 88: 10686–10690.
   PubMed Web of Science ®Google Scholar
• Weeks, D. L., and N. C. Jones 1983. E1A control of gene expression is mediated by sequences 5′ to the transcriptional starts of the early viral genes. Mol. Cell. Biol. 3: 1222–1234.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345–347.
   PubMed Web of Science ®Google Scholar
• Zanjani, E. D., G. Almeida-Porada, and A. W. Flake 1996. The human/sheep xenograft model: a large animal model of human hematopoiesis. Int. J. Hematol. 63: 179–192.
   PubMed Web of Science ®Google Scholar
• Zeng, Y. X., K. Somasundaram, and W. S. El-Deiry 1997. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15: 78–82.
   PubMed Web of Science ®Google Scholar
• Zhang, D. E., S. Hohaus, M. T. Voso, H. M. Chen, L. T. Smith, C. J. Hetherington, and D. G. Tenen 1996. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr. Top. Microbiol. Immunol. 211: 137–147.
   PubMed Web of Science ®Google Scholar
• Zweidler-McKay, P. A., H. L. Grimes, M. M. Flubacher, and P. N. Tsichlis 1996. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol. Cell. Biol. 16: 4024–4034.
   PubMed Web of Science ®Google Scholar